NPM1 and graft versus host disease: Using a meta-analytical approach to aggregate data from existing studies, we found that NPM1 mutations are enriched in MS sites compared to bone marrow with a high rate of molecular discordance, in addition to high rates of GVHD in post-HSCT relapse as MS and modest efficacy to VEN + HMA combination regimens.